Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Frederick Charles Morgan, M.D.

Concepts (73)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Basal Cell620245571.390 Why?
Skin Neoplasms15202458091.170 Why?
Papilloma120221400.740 Why?
Hamartoma Syndrome, Multiple120221140.730 Why?
Vascular Malformations120224680.530 Why?
Carcinoma, Squamous Cell6202240210.480 Why?
Mohs Surgery420242220.330 Why?
Health Expenditures2201823630.310 Why?
Dermatology420219180.300 Why?
Neoplasm Recurrence, Local6202392780.280 Why?
Skin1201944730.260 Why?
Health Care Costs1201832380.240 Why?
Melanoma2202256940.220 Why?
Early Detection of Cancer1201831960.220 Why?
Hyphae12021520.190 Why?
Nervous System Neoplasms12020910.170 Why?
Epidermis120215260.160 Why?
Lip Neoplasms12018360.150 Why?
Internship and Residency3202158790.140 Why?
Antifungal Agents120217530.130 Why?
Immunocompromised Host120218580.130 Why?
PTEN Phosphohydrolase1202211110.130 Why?
Neoplasm Staging32021111180.130 Why?
Neoplasm Invasiveness3202035910.130 Why?
Medicare3201867750.120 Why?
Cancer Care Facilities120184220.120 Why?
Retrospective Studies122023806730.120 Why?
Tumor Burden1201918920.110 Why?
Academic Medical Centers3201827570.110 Why?
Brachytherapy1201912230.100 Why?
Physicians, Primary Care120186180.090 Why?
Lymphatic Metastasis1201829130.090 Why?
Cohort Studies52022414860.070 Why?
Hospitals1202138810.070 Why?
Humans2020247610980.070 Why?
Risk Assessment42020240130.060 Why?
Massachusetts1201888360.060 Why?
Patient Selection1201642450.060 Why?
Female1120243924580.050 Why?
Head and Neck Neoplasms1201828960.050 Why?
Aged820241692660.050 Why?
Male1020243606750.040 Why?
Prognosis12021296720.040 Why?
Treatment Outcome32024646700.040 Why?
Personnel Selection120211960.040 Why?
Follow-Up Studies12019391210.040 Why?
Quality of Life12019133620.040 Why?
Disease-Free Survival2201868170.040 Why?
Sex Factors22024105520.040 Why?
Cross-Sectional Studies12018260680.030 Why?
Middle Aged620242208350.030 Why?
Preoperative Period120195510.030 Why?
United States62021723370.030 Why?
Lip120181970.030 Why?
Survival Analysis22018100830.030 Why?
Aged, 80 and over42024589460.030 Why?
Insurance Claim Review120177410.030 Why?
Risk Factors12019742190.030 Why?
Biopsy, Needle1201716240.030 Why?
Reoperation1201643040.020 Why?
Evidence-Based Medicine1201636890.010 Why?
Immunohistochemistry12017110660.010 Why?
Socioeconomic Factors1201778040.010 Why?
Adult420192210830.010 Why?
Survival Rate12017127270.010 Why?
Sensitivity and Specificity12018146760.010 Why?
Databases, Factual1201779690.010 Why?
Age Factors12017183850.010 Why?
Incidence12018213570.010 Why?
Practice Guidelines as Topic1201674000.010 Why?
Tomography, X-Ray Computed12016206000.010 Why?
Young Adult12019591990.010 Why?
Magnetic Resonance Imaging12016364180.000 Why?
Morgan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (73)
Explore
_
Co-Authors (8)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.